jnj.com Investor relations The J&J value At Johnson & Johnson, we believe health is everything. We are building a world where complex diseases are prevented, treated and cured, treatments are smarter and less invasive and solutions are personal. About Johnson & Johnson Delivering long-term ...
Learn moreInnovative Medicine pipeline Environmental, social, and governance Learn moreabout Environmental, social, and governance Information on tax basis following Kenvue separation Questions? Please contact us: 1-800-950-5089investor-relations@its.jnj.com...
Investor relations The J&J value At Johnson & Johnson, we believe health is everything. We are building a world where complex diseases are prevented, treated and cured, treatments are smarter and less invasive and solutions are personal.
Prior to assuming his current duties, Joe was the Vice President of Investor Relations for Johnson & Johnson. In this role, he developed a winning strategy for building strong relationships with the investment community and disseminating Johnson & Johnson’s value creation narrative to all external ...
Johnson & [ABSTRACT FROM PUBLISHER]Investor's Business DailyInvestors Business Daily
DARZALEX and DARZALEX FASPRO; Genmab A/S; BALVERSA: Astex Pharmaceuticals; ERLEADA: Regents of California and Memorial Sload Kettering; CARVYKTI: Legend Biotech; AKEEGA: TESARO, an oncology-focused business within GSK; lazertinib: Yuhan Corporation; Duobody Platform bispecific antibody programs: Genma...
As a reminder, you can find additional materials, including today's presentation and associated schedules on the investor relations section of the Johnson & Johnson website at investor.jnj.com. Please note that this presentation contains forward-looking statements regarding, among other things, company...
1Decision Resources (DRG) 2023 Report # # # Media contact: Brian Kenney 212-620-0111 Suzanne Frost 416-317-0304 Investor contact: Rachel Kruper investor-relations@its.jnj.com
1Decision Resources (DRG) 2023 Report # # # Media contact: Brian Kenney 212-620-0111 Suzanne Frost 416-317-0304 Investor contact: Rachel Kruper investor-relations@its.jnj.com
hnson & Johnson.]]>Johnson & [ABSTRACT FROM PUBLISHER]Investor's Business DailyInvestors Business Daily